PluroGen Therapeutics, Inc.
503 Broadleaf Way
Charlottesville, VA 22911
Tel: 443 994 0101
Fax: 410 990 9817
www.plurogen.com
503 Broadleaf Way
Charlottesville, VA 22911
Tel: 443 994 0101
Fax: 410 990 9817
www.plurogen.com
| News Release |
FOR IMMEDIATE RELEASE Contact: Neal G. Koller
President & CEO
4 November 2009 Board of Directors
443 994 0101
PLUROGEN THERAPEUTICS INC. AND COMPOUNDING Rx APOTHECARY, INC.
SIGN SUPPLY & DISTRIBUTION AGREEMENT
FOR PLUROGEN’S PLUROGEL® HYDROGEL PRODUCTS
(Charlottesville, VA, November 4, 2009) – PluroGen Therapeutics, Inc. today announced the signing of a
supply and distribution agreement with Compounding Rx Apothecary, Inc. (Malvern, PA) for Compounding
Rx Apothecary to formulate and market custom topical products based on PluroGen’s proprietary topical
PluroGel® hydrogel technology.
Commenting on the agreement, Neal G. Koller, President & CEO of PluroGen, said, “Establishing this
relationship with Compounding Rx Apothecary provides an excellent channel for our PluroGel® hydrogel
technology to reach the custom compounding human and veterinary markets. We are excited that this
arrangement will extend our product offerings into these two growing markets.”
Eric Fox, President of Compounding Rx Apothecary, said “Compounding Rx Apothecary has a well-
established custom compounding business for topical products, both to the human and veterinary
markets. Adding the benefits of PluroGen’s hydrogel technology to our compounding will provide us with
new, unique and differentiated products, with proven, advantageous therapeutic options for both our
patients and physicians.”
About PluroGen Therapeutics, Inc.
PluroGen is a burn, wound and skin care company commercializing our multiple patent-protected
technology platforms, the 1st of which is our core gel technology that provides superior and differentiated
physical, bio-impact and multi-function benefits. Our multiple technology platforms are configurable to
deliver a wide variety of medicinal and beneficial compounds as protected and advanced therapeutic and
topical products for simple and complex skin care and burn and wound healing. PluroGen’s product
pipeline targets improved, protected therapies for the 6 areas of treatment in tissue management and
healing (cleansing, infection, pain, inflammation, tissue salvage, tissue regeneration).
PluroGen’s first gels, PluroGel® and ActiviGel™, are being used initially in skin and wound cleansing
products, for personal skin care products and for two branded topical antimicrobial products, PluroGel®
Barrier Gels and PluroGel® Barrier Dressings. PluroGel® / ActiviGel™ technology is currently in routine use
at the University of Virginia Medical Center, having shown superior results on more than 2,000 patients in
two different patient populations, severe burns and chronic wounds. The PluroGen management and
operational teams, Boards and Principal Investigators are recognized global clinical and commercial
leaders in PluroGen’s target markets of burn and wound care and in the life sciences industry.
For more information about PluroGen Therapeutics, Inc., visit the Company’s web site at www.plurogen.
com.
About Compounding Rx Apothecary
Compounding Rx Apothecary is a fully equipped state of the art compounding pharmacy. Our mission is to
maximize patient outcomes by working together with physicians and patients to solve individual
medication administration or dosing issues. Patients are individual and unique, with specific physiological
make ups, wants, needs, likes and dislikes. There is no one size fits all in healthcare, and that is why we
compound customized medications. Whether it is putting a medication into a transdermal form to target
specific joints or limbs or avoid high systemic concentrations, making a pediatric dose when only adult
doses are available commercially, compounding a medication when it is not available due to a national
shortage, or preparing any dosage form necessary to get a medication into a patient when traditional
methods or doses are not appropriate, we can help.
For more information about Compounding Rx Apothecary, Inc., visit the Company’s web site at www.
compoundingrxapothecary.com.
Statements included in this press release that are not historical in nature are "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act of 1995. The Company cautions readers that
forward-looking statements are subject to certain risks and uncertainties, which could cause actual results to
differ materially and which are identified from time to time in the Company’s reports filed with the U.S.
Securities and Exchange Commission. PluroGen Therapeutics, Inc. claims the protection of the Safe Harbor for
forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.
Information included on PluroGen Therapeutics, Inc website or Compounding Rx Apothecary website is not
incorporated herein by reference or otherwise.
President & CEO
4 November 2009 Board of Directors
443 994 0101
PLUROGEN THERAPEUTICS INC. AND COMPOUNDING Rx APOTHECARY, INC.
SIGN SUPPLY & DISTRIBUTION AGREEMENT
FOR PLUROGEN’S PLUROGEL® HYDROGEL PRODUCTS
(Charlottesville, VA, November 4, 2009) – PluroGen Therapeutics, Inc. today announced the signing of a
supply and distribution agreement with Compounding Rx Apothecary, Inc. (Malvern, PA) for Compounding
Rx Apothecary to formulate and market custom topical products based on PluroGen’s proprietary topical
PluroGel® hydrogel technology.
Commenting on the agreement, Neal G. Koller, President & CEO of PluroGen, said, “Establishing this
relationship with Compounding Rx Apothecary provides an excellent channel for our PluroGel® hydrogel
technology to reach the custom compounding human and veterinary markets. We are excited that this
arrangement will extend our product offerings into these two growing markets.”
Eric Fox, President of Compounding Rx Apothecary, said “Compounding Rx Apothecary has a well-
established custom compounding business for topical products, both to the human and veterinary
markets. Adding the benefits of PluroGen’s hydrogel technology to our compounding will provide us with
new, unique and differentiated products, with proven, advantageous therapeutic options for both our
patients and physicians.”
About PluroGen Therapeutics, Inc.
PluroGen is a burn, wound and skin care company commercializing our multiple patent-protected
technology platforms, the 1st of which is our core gel technology that provides superior and differentiated
physical, bio-impact and multi-function benefits. Our multiple technology platforms are configurable to
deliver a wide variety of medicinal and beneficial compounds as protected and advanced therapeutic and
topical products for simple and complex skin care and burn and wound healing. PluroGen’s product
pipeline targets improved, protected therapies for the 6 areas of treatment in tissue management and
healing (cleansing, infection, pain, inflammation, tissue salvage, tissue regeneration).
PluroGen’s first gels, PluroGel® and ActiviGel™, are being used initially in skin and wound cleansing
products, for personal skin care products and for two branded topical antimicrobial products, PluroGel®
Barrier Gels and PluroGel® Barrier Dressings. PluroGel® / ActiviGel™ technology is currently in routine use
at the University of Virginia Medical Center, having shown superior results on more than 2,000 patients in
two different patient populations, severe burns and chronic wounds. The PluroGen management and
operational teams, Boards and Principal Investigators are recognized global clinical and commercial
leaders in PluroGen’s target markets of burn and wound care and in the life sciences industry.
For more information about PluroGen Therapeutics, Inc., visit the Company’s web site at www.plurogen.
com.
About Compounding Rx Apothecary
Compounding Rx Apothecary is a fully equipped state of the art compounding pharmacy. Our mission is to
maximize patient outcomes by working together with physicians and patients to solve individual
medication administration or dosing issues. Patients are individual and unique, with specific physiological
make ups, wants, needs, likes and dislikes. There is no one size fits all in healthcare, and that is why we
compound customized medications. Whether it is putting a medication into a transdermal form to target
specific joints or limbs or avoid high systemic concentrations, making a pediatric dose when only adult
doses are available commercially, compounding a medication when it is not available due to a national
shortage, or preparing any dosage form necessary to get a medication into a patient when traditional
methods or doses are not appropriate, we can help.
For more information about Compounding Rx Apothecary, Inc., visit the Company’s web site at www.
compoundingrxapothecary.com.
Statements included in this press release that are not historical in nature are "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act of 1995. The Company cautions readers that
forward-looking statements are subject to certain risks and uncertainties, which could cause actual results to
differ materially and which are identified from time to time in the Company’s reports filed with the U.S.
Securities and Exchange Commission. PluroGen Therapeutics, Inc. claims the protection of the Safe Harbor for
forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.
Information included on PluroGen Therapeutics, Inc website or Compounding Rx Apothecary website is not
incorporated herein by reference or otherwise.